295 related articles for article (PubMed ID: 25301447)
1. Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.
Kryštůfková O; Barbasso Helmers S; Venalis P; Malmström V; Lindroos E; Vencovský J; Lundberg IE
Arthritis Res Ther; 2014 Oct; 16(5):454. PubMed ID: 25301447
[TBL] [Abstract][Full Text] [Related]
2. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies.
López De Padilla CM; McNallan KT; Crowson CS; Bilgic H; Bram RJ; Hein MS; Ytterberg SR; Amin S; Peterson EJ; Baechler EC; Reed AM
J Rheumatol; 2013 Mar; 40(3):294-302. PubMed ID: 23322463
[TBL] [Abstract][Full Text] [Related]
3. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies.
Eloranta ML; Barbasso Helmers S; Ulfgren AK; Rönnblom L; Alm GV; Lundberg IE
Arthritis Rheum; 2007 Sep; 56(9):3112-24. PubMed ID: 17763410
[TBL] [Abstract][Full Text] [Related]
4. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
5. Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
Yamaguchi K; Tang Q; Poland P; Reay DP; Gregory A; Aggarwal R; Oddis CV; Ascherman DP
Front Immunol; 2024; 15():1399451. PubMed ID: 38895121
[TBL] [Abstract][Full Text] [Related]
6. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
[TBL] [Abstract][Full Text] [Related]
8. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
9. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
[TBL] [Abstract][Full Text] [Related]
10. Profile of BAFF and its receptors' expression in lupus nephritis is associated with pathological classes.
Suso JP; Posso-Osorio I; Jiménez CA; Naranjo-Escobar J; Ospina FE; Sánchez A; Cañas CA; Tobón GJ
Lupus; 2018 Apr; 27(5):708-715. PubMed ID: 29087261
[TBL] [Abstract][Full Text] [Related]
11. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
12. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
Zhao LD; Li Y; Smith MF; Wang JS; Zhang W; Tang FL; Tian XP; Wang HY; Zhang FC; Ba DN; He W; Zhang X
Lupus; 2010 Nov; 19(13):1534-49. PubMed ID: 20974656
[TBL] [Abstract][Full Text] [Related]
13. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
[TBL] [Abstract][Full Text] [Related]
14. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
[TBL] [Abstract][Full Text] [Related]
15. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.
Wada K; Maeda K; Tajima K; Kato T; Kobata T; Yamakawa M
Histopathology; 2009 Jan; 54(2):221-32. PubMed ID: 19207947
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis.
Kryštůfková O; Hulejová H; Mann HF; Pecha O; Půtová I; Ekholm L; Lundberg IE; Vencovský J
Arthritis Res Ther; 2018 Jul; 20(1):158. PubMed ID: 30053824
[TBL] [Abstract][Full Text] [Related]
18. Regulated expression of BAFF-binding receptors during human B cell differentiation.
Darce JR; Arendt BK; Wu X; Jelinek DF
J Immunol; 2007 Dec; 179(11):7276-86. PubMed ID: 18025170
[TBL] [Abstract][Full Text] [Related]
19. The activation of BAFF/APRIL system in spleen and lymph nodes of Plasmodium falciparum infected patients.
Dechkhajorn W; Benjathummarak S; Glaharn S; Chaisri U; Viriyavejakul P; Maneerat Y
Sci Rep; 2020 Mar; 10(1):3865. PubMed ID: 32123265
[TBL] [Abstract][Full Text] [Related]
20. Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients.
Hulejová H; Kryštůfková O; Mann H; Klein M; Pavlíčková K; Zámečník J; Vencovský J; Šenolt L
Clin Exp Rheumatol; 2016; 34(2):222-9. PubMed ID: 26886056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
